Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Letai

Showing results (61-70 of 182) with videos related to

Pageof 19
Sort By:
Trends in Cancer|June 18, 2022
Challenges and opportunities for physician-scientists in advancing cancer researchNancy E Davidson, Richard J Gilbertson, Anthony Letai, et al.
Human Molecular Genetics|August 15, 2009
Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c releaseAlison K Berger, Giuseppe P Cortese, Katherine D Amodeo, et al.
The Journal of Clinical Investigation|January 4, 2007
Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737Victoria Del Gaizo Moore, Jennifer R Brown, Michael Certo, et al.
EMBO Reports|July 11, 2018
Phosphorylation switches Bax from promoting to inhibiting apoptosis thereby increasing drug resistanceJustin Kale, Ozgur Kutuk, Glauber Costa Brito, et al.
Blood Advances|July 10, 2023
Targeting conditioned media dependencies and FLT-3 in chronic lymphocytic leukemiaSalma Parvin, Aditi Aryal, Shanye Yin, et al.
Cancer Cell|May 16, 2006
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family membersMichael Certo, Victoria Del Gaizo Moore, Mari Nishino, et al.
Science Signaling|December 25, 2014
RAS signaling promotes resistance to JAK inhibitors by suppressing BAD-mediated apoptosisPeter S Winter, Kristopher A Sarosiek, Kevin H Lin, et al.
Nature Communications|May 20, 2023
Dynamic BH3 profiling identifies pro-apoptotic drug combinations for the treatment of malignant pleural mesotheliomaDanielle S Potter, Ruochen Du, Stephan R Bohl, et al.
Haematologica|October 26, 2023
BH3 profiling as pharmacodynamic biomarker for the activity of BH3 mimeticsRongqing Aaron Pan, Youzhen Wang, Shumei Qiu, et al.
Cells|August 7, 2021
ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic ProteinsClara Alcon, Jorge Gómez Tejeda Zañudo, Reka Albert, et al.
Pageof 19

Showing results (61-70 of 182) with videos related to

Sort By:
Pageof 19
Trends in Cancer|June 18, 2022
Challenges and opportunities for physician-scientists in advancing cancer researchNancy E Davidson, Richard J Gilbertson, Anthony Letai, et al.
Human Molecular Genetics|August 15, 2009
Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c releaseAlison K Berger, Giuseppe P Cortese, Katherine D Amodeo, et al.
The Journal of Clinical Investigation|January 4, 2007
Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737Victoria Del Gaizo Moore, Jennifer R Brown, Michael Certo, et al.
EMBO Reports|July 11, 2018
Phosphorylation switches Bax from promoting to inhibiting apoptosis thereby increasing drug resistanceJustin Kale, Ozgur Kutuk, Glauber Costa Brito, et al.
Blood Advances|July 10, 2023
Targeting conditioned media dependencies and FLT-3 in chronic lymphocytic leukemiaSalma Parvin, Aditi Aryal, Shanye Yin, et al.
Cancer Cell|May 16, 2006
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family membersMichael Certo, Victoria Del Gaizo Moore, Mari Nishino, et al.
Science Signaling|December 25, 2014
RAS signaling promotes resistance to JAK inhibitors by suppressing BAD-mediated apoptosisPeter S Winter, Kristopher A Sarosiek, Kevin H Lin, et al.
Nature Communications|May 20, 2023
Dynamic BH3 profiling identifies pro-apoptotic drug combinations for the treatment of malignant pleural mesotheliomaDanielle S Potter, Ruochen Du, Stephan R Bohl, et al.
Haematologica|October 26, 2023
BH3 profiling as pharmacodynamic biomarker for the activity of BH3 mimeticsRongqing Aaron Pan, Youzhen Wang, Shumei Qiu, et al.
Cells|August 7, 2021
ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic ProteinsClara Alcon, Jorge Gómez Tejeda Zañudo, Reka Albert, et al.
Pageof 19